MEDICINOVA, INC. Deferred Revenue Recognized
MEDICINOVA, INC. (MNOV) reported Deferred Revenue Recognized of $500.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-13
- MEDICINOVA, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $500.00K, a 400.00% increase year-over-year.
- MEDICINOVA, INC. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $200.00K.
- MEDICINOVA, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $100.00K.
- MEDICINOVA, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $100.00K.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $500.00K 10-Q · filed 2026-08-13 | $600.00K 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $400.00K 10-Q · filed 2026-08-13 | |||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-12 | $300.00K 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-14 | $100.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |